Type 1 diabetes (T1D) is characterized by intrinsic immune destruction of β-cell, and insulin-dependent treatment to achieve euglycemia results in substantial glycemic variability (GV) [1]. The gene discussed is INS; the disease is type 1 diabetes mellitus.